Cefepime for Ceftriaxone-Resistant Enterobacterales With Chromosomal AmpC β-Lactamases
- PMID: 36974628
- DOI: 10.1093/cid/ciad173
Cefepime for Ceftriaxone-Resistant Enterobacterales With Chromosomal AmpC β-Lactamases
Conflict of interest statement
Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
Comment in
-
Reply to Davis et al.Clin Infect Dis. 2023 Jul 5;77(1):163-165. doi: 10.1093/cid/ciad170. Clin Infect Dis. 2023. PMID: 36978246 No abstract available.
Comment on
-
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections.Clin Infect Dis. 2022 Jul 6;74(12):2089-2114. doi: 10.1093/cid/ciab1013. Clin Infect Dis. 2022. PMID: 34864936 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
